IPO registrations (S-1, F-1) · Registrants
Glucose Health, Inc.
- SEC CIK
- 1420108 · filings on EDGAR ↗
- Former names
- Bio-Solutions Corp. (2007–2014)
- Registration
- Form S-1, first filed 2009-03-20, last 2023-01-09; 2 initial registrations, 4 amendments
- Outcome
- Declared effective 2009-05-06; withdrawal requested 2023-06-28
- Industry (SIC)
- Medicinal Chemicals & Botanical Products 2833
- Incorporated in
- DE
- Business address
- 609 SW 8TH STREET, SUITE 600, Bentonville, AR 72712
- EIN
- 90-1117742
- Ticker
- GLUC (OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Glucose Health, Inc. on the corporate pages
On this site
- Form D issuer: Glucose Health, Inc. EXACT (CIK (EXACT))
- SEC filer: Glucose Health, Inc. EXACT (CIK (EXACT))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2009-03-20 | S-1 | S-1 (registration) | Bio-Solutions Corp. | 0001402973-09-000020 ↗ |
| 2009-04-23 | S-1/A | S-1/A (amendment) | Bio-Solutions Corp. | 0001402973-09-000035 ↗ |
| 2009-05-06 | EFFECT | EFFECT (declared effective) | Bio-Solutions Corp. | 9999999995-09-001316 ↗ |
| 2022-06-01 | S-1 | S-1 (registration) | Glucose Health, Inc. | 0001477932-22-004038 ↗ |
| 2022-08-05 | S-1/A | S-1/A (amendment) | Glucose Health, Inc. | 0001477932-22-005660 ↗ |
| 2022-09-06 | S-1/A | S-1/A (amendment) | Glucose Health, Inc. | 0001477932-22-006657 ↗ |
| 2023-01-09 | S-1/A | S-1/A (amendment) | Glucose Health, Inc. | 0001477932-23-000175 ↗ |
| 2023-06-28 | RW | RW (withdrawal request) | Glucose Health, Inc. | 0001477932-23-004855 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| FLEMING MURRAY | Officer,TenPercentOwner | CEO, CFO | 1 | 2015 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-09-10 | Glucose Health, Inc. | Manufacturing | $30,000 | $10,000 | 1 | 1 |
| 2026-07-07 | Glucose Health, Inc. | Manufacturing | $120,000 | $60,000 | 1 | 1 |
| 2026-02-04 | Glucose Health, Inc. | Manufacturing | $100,000 | $100,000 | 1 | 1 |
| 2025-12-05 | Glucose Health, Inc. | Manufacturing | $20,000 | $20,000 | 2 | 1 |
| 2023-12-07 | Glucose Health, Inc. | Manufacturing | $290,000 | $290,000 | 5 | 2 |
| 2021-03-09 | Glucose Health, Inc. | Manufacturing | $960,000 | $960,000 | 10 | 1 |
| 2020-06-19 | Glucose Health, Inc. | Manufacturing | $300,000 | $300,000 | 8 | 1 |
| 2020-05-12 | Glucose Health, Inc. | Manufacturing | $65,000 | $65,000 | 4 | 1 |
| 2019-05-03 | Glucose Health, Inc. | Manufacturing | $460,000 | $460,000 | 4 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.